Therapixel
Imaging AI software that helps radiologists detect breast cancer in mammography screening
Highlights
- New on EvolcAdded 2026-10-29
About Therapixel
Therapixel is a French software publisher that develops artificial intelligence applied to medical imaging. Its flagship product is MammoScreen, an AI solution for breast cancer detection in mammography.
Its customers are medical imaging and screening stakeholders; the business model is software publishing. The company is registered in Nice, France, and was founded in 2013. It has been involved in national French studies on AI in breast cancer screening and in R&D projects such as AURELIA.
The website lists a team page, press section, news and events, and an investor section.
Product: MammoScreen, AI software for breast cancer detection in medical imaging
Jobs at Therapixel
More health & medtech companies
Theremia
AI models for optimising drug dosing and formulation in neurology and psychiatry, sold to biotech drug developersYoung companyNew on EvolcTherenva
AI-based endovascular planning and C-arm image fusion software for interventional cardiologists and vascular surgeonsNew on EvolcTheryq
Radiotherapy machines with linear accelerators, using FLASH technology, for cancer treatment centresNew on EvolcThinkin Tech
Wearable ultrasound guidance devices for aesthetic practitioners performing dermal filler injectionsYoung companyNew on EvolcTilak Healthcare
Remote monitoring app for ophthalmologists and patients with chronic retinal conditionsNew on EvolcTildev
Digital patient-care reporting and emergency-response coordination software for healthcare and emergency services organizationsNew on Evolc
Website technologies
Older, unverified list. Detection dates and supporting evidence are not yet available.
- Apache
- Cookiebot
- PHP
- WordPress
- jQuery